RJ Reynolds
the Health Risks of Passive Smoking.
Fields
- Type
- REPORT
- Site
- Law
- Ward Me
- Asst Counsel
- Ward Me
- Request
- 1rfp93
- Minnesota
- 1rfp41
- Minnesota
- Referenced Document
- List of Study Authors. Iarc Monographs on the Evaluation of the Carcinogenic Risk of Chemicals to Humans, 860000. Ets: Measuring Exposures and Assessing Health Effects, by Natl Research Council, 860000. The Health Consequences of Involuntary Smoking, by U
- Date Loaded
- 15 Jun 1999
- Named Person
- Off, O.F. Air & Radiation
- Bayard, S.
- Brown, K.
- Humble, C.G.
- Crawfordbrown, D.
- Thorslund, T.
- Lewtas, J.
- Epa
- Koppikar, A.
- Us Surgeon General
- Hirayama
- Wuwilliams
- Samet
- Bayard, S.
- Author
- Bayard, S.
- Epa
- Box
- Rjr3761
- Characteristic
- Marginalia
- UCSF Legacy ID
- btm92d00
Document Images
ETS and Lung Cancer
"The absence of a threshold for respiratory
carcinogenesis -in active smoking, the presence of
the same carcinogens in mainstream and
sidestream smoke, the demonstrated uptake of
tobacco smoke constituents by involuntary
smokers, and the demonstration of an increased
lung cancer risk in some populations with
exposures to ETS leads to the conclusion that
involuntary smoking is a cause of lung cancer."
The Health Consequences of Involuntary Smoking (U.S.
Surgeon General, 1986)
OtiLZ OLSZS

Bayard

ETS and Lung Cancer
"Examination of smoke from the different sources shows that all three types
contain chemicals that are both carcinogenic and mutagenic. The
amounts absorbed by passive smokers are, however, small, and effects
are unlikely to be detectable unless exposure is substantial and very large
numbers of people are observed. The observations on nonsmokers that
have been made so far are compatible with either an increased risk from
'passive' smoking or an absence of risk. Knowledge of the nature of
SirlclStrcnam anrm mainstrnar~ Smnlsn7 nf thn matorials ahsnrhorl rle er'nrs
I%..v a9 v o.. I I%.. III n~ .~v III II1v~ v v~ .~~v ~~~ a~~~ ~ v v1 a/vv %..vl if Iy
'passive' smoking, and of the quantitative relationships between dose and
effect that are commonly observed from exposure to carcinogens,
however, leads to the conclusion that passive smoking gives rise to some
risk of cancer."
--~ There is sufficient evidence that tobacco smoke is carcinogenic to
humans.
-
IARC Monographs on the evaluation of the carcinogenic risk of chemicals to humans.
Vol 38 Tobacco Smoking, 1986.
Zt'LZ OLSTS

Uniqueness of ETS for EPA
1. Wealth of human studies at true environmental levels.
(3 cohort and 21 case-control)
A. Smaller expected relative risks
B. Use of meta analysis to combine
results
C. No need to use mathematical models
for low-dose extrapolation
2. Knowledge that ETS contains the same chemical
constituents as mainstream cigarette smoke - known
human carcinogen - and that the lung is exposed to both
forms.
jSLZ 0L5ti5

Health Eftcts of Passive Sr.:oking: Lung Cancer in Adults and
Respiratory Disorders in Children
Prepared By:
U. S. EPA
OFFICE OF RESEARCH AND DEVELOPMENT
OFFICE OF HEALTH AND ENVIRONMENTAL ASSESSMENT
Human Health Assessment Group
At the Request of (major fundingJ:
OFFICE OF AIR AND RADIATION
OFFICE OF ATMOSPHERIC AND INDOOR AIR PROGRAMS
Indoor Air Division
PROJECT MANAGER Steven Bayard, Ph.D.
PRIMARY AUTHORS
Ch. 2-5, App. B Kenneth Brown, Ph.D.
Appendix A Charles G. Humble
Appendix C Douglas Crawford-Brown, Ph.D.
Appendix D Todd Thorslund, Sc.D.
ALSO HERE TODAY
EPA Research on ETS Joellen Lewtas, Ph.D.
Ch. 5 Apama Koppikar, M.D., Ph.D.
LELZ OLSiS

Ste ven Ba yard, Ph. D.
Presentation before the Science Advisory Board
on
The Health Risks of Passive Smoking
December 4 - 5, 1990
9ELZ OLSTS

IARC GROUP 1 AGENTS
KNOWN HUMAN CARCINOGENS
IARC MONOGRAPHS SUPPLEMENT 7,1987
50 AGENTS
Melphalan
8-Methoxypsoralen (Methoxsalen) plus
ultraviolet radiation
Mineral oils, untreated and mildly-treated
MOPP (combined therapy with nitrogen
mustard, vincristine, procarbazine and
prednisone) and other combined
chemotherapy including alkylating
agents
Mustard gas (Sulphur mustard)
+ 2-Naphthyiamine
+ Nickel and nickel compounds'
Oestrogen replacement therapy
Oestrogens, nonsteriodal'
Oestrogens, steroidal'
Oral contraceptives, combinedi
Oral contraceptives, sequential
The rubber industry
Shale-oils
+ Soots
Talc containing asbestiform fibres
-Abo.. TosvaQ+ccv prvVVCts, .s7rl~iokeie~3J
'~ Tobacco smoke
Treosulphan
+ Vinyl chloride
'This evaluation applies to the group of chemicals as a whole and not necessarily to alt individual
chemicals within the group
(see also Methods, p. 38).
+Identitied in ETS
~f1LZ 0LST5

CONCLUSION
ETS is causally associated with Lung Cancer
(EPA Group A) based on:
1. Consistency of Response
2. Association
3. Consistent Dose - Response Trend
4. Effects Remain After Adjustment for Bias
5. Broad-based Evidence
6. Biological Plausibility
7. Collateral Evidence
SS` Z 0Z S rS

ETS and Lung Cancer
"The weight of evidence derived from epidemiologic
studies shows an association between ETS
exposure of nonsmokers and lung cancer that
taken as a whole is unlikely to be due to chance or
system atic bias." pg. 245
"Considering the evidence as a whole, exposure to
ETS increases the incidence of lung cancer in
nonsmokers." pg. 10
. ETS: Measuring Exposures and Assessing Health Effects
(National Research Council, 1986)
jiILZ OLSTS

CONCL USIONS
A. L UNG CANCER IN ADUL TS
1. ETS is a Group A or known human carcinogen. (Hazard
idei iti f icatioi i or 'viieig h t-of-evidence)
2. ETS causes on estimated 3,700 lung cancer deaths per
year among non-smoking adults aged 35 and over. The
confidence limits are 1,700 and 6,000 (quantitative
assessment).
8ELZ 0LSt5

EPA Carcinogen Assessment Guidelines
Overall Weight of Evidence for Human Carcinogenicity
Group A This group is used only when there is sufficient
evidence from epidemiologic studies to
support a causal association between
exposure to the agents and cancer.
Group B This group includes agents for which the weight
of evidence of human carcinogenicity based
on epidemiologic studies is "limited".
pg. 1-12
9t,(,z OLSIS
' /n

Current EPA Group A Carcinogens -15 Agents
+' Arsenic
' Asbestos
Benzene
Benzidine
' Bis (chioromethyl) ether [BCME]
' Chromium (Hexavalent)
Coke oven emissions
' Diethylstilbestrol [DES]
o Direct Black 38
o Direct Blue 6
o Direct Brown 95
+' 2-Napthylamine
+` Nickel Refinery Dust, Nickel Subsulfide
' Radon
+' Vinyl Chloride
St'LZ OLSTS
' IARC Group 1
o IARC Group 2A
+ identitied in ETS

CONCLUSIONS
B. RESPIRA TORY DISORDERS IN CHILDREN
1. ETS exposure from parental smoking,
especially during infancy is associated with
increased prevalence of acute lower
respiratory tract infections, respiratory
symptoms of irritation and middle ear
eff usions.
2. ETS exposu re is associated with reduced l u ng
function and with a small reduction in the rate
of pulmonary growth and development in
children of mothers who smoke during early
childhood.
6CLZ OLSiS

LUNG CANCER RELATIVE RISK FROM HIRAYAMA STUDY (1984),
AGE-ADJUSTED BY WIFE'S AGE
2.5
2.0
0
f-
4
Q 1.5
Y
N
~
R
W
U
z
V
.0
(7
z
0.6
0.0
(1-TAILED TEST FOR TREND, P=.001)
NONSMOKER EXSMOKER/1-19 CPD
SPOUSES' SMOKING CATEGORY
1.74
20+ CPD
OSLZ OLSLS

EPA Carcinogen Assessment Guidelines
pg. 1-11
Three criteria must be met for a causal association to be
inferred between exposure and cancer in humans.
1 . There is no identified bias that could explain the
association.
2. The possibility of confounding has been considered
and ruled out as explaining the association.
3. The association is unlikely, to be due to chance.
In general, although a single study may be indicative of a
cause-effect relationship, confidence in inferring a
causal association is increased when several
independent studies are concordant in showing the
association, when the association is strong, when
there is a dose-response relationship, or when a
reduction in exposure is followed by a reduction in the
incidence of cancer.
LVLZ OLSTS
/ /

Other Criteria for Causality - none should be considered either necessary or
sufficient in itself.
1. Consistency - usually two or more epidemiologic studies.
2. Strength (magnitude) of- association - increased risk of cancer typically
greater than 5.
3. Temporality - exposure occurs before disease.
4. Dose-Response - a strong dose-response relationship across several
categories of exposure can be strong evidence for
causality if confounding effects are unlikely to be
associated with dose.
5. Specificity of the association
6. Biological Plausibility cosistent with what is known about biological
mechanisms, biology and natural history of the
7. Collateral Evidence disease.
8t'LZ OLStS
/z

ETS AND THE USE OF META ANALYSIS
II. Quantitative Assessment:
M14 , . .
~
19
Case-Control
3
Cohort
Combined
Unadjusted
Adjusted for
Misclassification
Adjusted for
Misclassification
plus background
Population
Attributable Risk
Annual Attributable
Lung cancer deaths
to non-smokers
do to ETS (all sources)
1.42 (1.24, 1.63) 1.39 (1.15, 1.67) .1.41 (1.26, 1.57)
-------- 1.28 (1.12, 1.45)
-------- -------- 1.48 (1.21, 1.87)
-------- --------
0.26 '
~ --------
~ -------- 3,700 ` (1700, 6000)
* Slightly less than values given in report due to error in formula B-3
9SLZ OLSIS

E T S and the Use of Meta Anaiysis - Hazard identification
Meta Analysis The statistical analysis of a large collection
of analysis results from individual
studies for the purpose of integrating the
findings.
Association In(ODDS RATIO) i
S. -
-
° S. E. In(ODD RATIO)~
under H o: Relative Risk = 1
and
Si - N (0,1)
P is the one-tailed test value
Causal Association * extended Mantel-Haenzel test for
trencLllnder H o: slope = 0
Pslope is the one-tailed test value
* overall relative risk estimate and
z5~z OLSTS adjustment for misclassification

L UNG CANCER 1?ELAT!VE RlSK FROM .!APAIdcSC PROSPECTIVE STUDY OF Q., ..
54^ WOMEN,
.,. .
BY DAILY CIGARETTE CONSUMPTION OF SPOUSE, AGE ADJUSTED BY HUSBANDS' AGE.
14-YEAR FOLLOWUP; 200 TOTAL CASES. NO MISCLASS. BIAS EXPECTED iN
PROSPECTIVE STUDY. (HIRAYAMA, 1984)
(1-TAILED TEST FOR TREND, P= .002)
1.58
1.42
1.36
1.91
NONSMOKER EXSMOKER 1-14 CPD 15-19 CPD >20 CPD
SPOUSES' SMOKING CATEGORY (CIG/DAY)
6vLZ aLStS

Calculation of Population Attributable Risk (PAR)
Assu'rrme 60% female non-smokers married to a smoker = P(E/N)
40% female non-smokers married to a non-smoker =' (1- P(E/N)
% Unmarrieds exposed to ETS = % Marrieds exposed to ETS
Relative Risk
females N.S. married to a smoker = RRB = 1.48
truley unexposed
Relative Risk female N.S. married to a non-smoker
truly unexposed
= RRB _ 1.16
RRM
PAR males = PAR females
PAR =
Excess Risk due to ETS Ex~o, ure_
total risk from all sources
P(E/N) (RRB-1) + l1 -P(E/N) ~R .26 P(E/N)RRB+(1-P(E/N) R (.149.41)
~ ~ o
95 /o C l
LSLZ OLSTS

IA°C GRO:lD 1 AGENTS
KNOWN HUMAN CARCINOGENS
IARC MONOGRAPHS SUPPLEMENT 7, 1987
50 AGENTS
Aflatoxins
Aluminum production
+ 4-Aminobiphenyl
Analgesic mixtures containing phenacetin
+ Arsenic and arsenic compounds'
Asbestos
Auramine, manufacture of
Azathioprine
+ Benzene
Benzidine
-W- Betel quid with tobacco
N,N-Bis(2-chloroethyl)-2-naphthyiamine
(Chiornaphazine)
Bis(chioromethyl)ether and chloromethyl
methyl ether (technical-grade)
Boot and shoe manufacture and repair
1,4-Butanedioi dimethanesuiphonate
(Myleran)
Chlorambucil
1-(2-Chioroethyl)-3-(4-methyicyclohexyl)-1-n
itrosourea (Methyl-CCNU)
+ Chromium compounds, hexavaient'
Coal gasification
Coal-tar pitches
Coal-tars
Coke production
Cyclophosphamide
Diethylstilboestrol
Erionite
Furniture and cabinet making
Haematite mining, undergound, with
exposure to radon
Iron and steel founding
Isopropyl alcohol manufacture, strong-acid
process
Magenta, manufacture of
'This evaluation applies to the group of chemicals as a whole and not necessarily to all individual
chemicals within the group
(see also Methods, p. 38).
+Identified in ETS
EtiLZ OLSTS

ETS AND THE USE OF META ANALYSIS
i. Hazard Identification - Qualitative Assessment
A. Association : Case-Control Studies Only
S Statistic based on odds ratio
S
UNADJUSTED ANALYSIS
TABLE,¢5
19 CASE-CONTROL
ADJUSTED ANALYSIS
TABLE 3-6
12 CASE-CONTROL
PS
P°
01 4 False + at
05 Ievel
P<.001
P<.001 .
10 Fa lse + a'r.101eve l
P=.01 - P<.001 5 False + af.05 Ievel
B. Causal Association : Case-Control + Cohort Studies
Number of Studies Pvalue
i. Adjustment for Misclassification Bias
ii. Dose-Response Trend '
a. No. CiglDay
b. No. of years smoking
* Based on Wu-Williams and Samet. (1990)
19 CAS E-CONTROL
3 COHORT P <.01 Overall Relative Risk
Adjusted
10 CAS E-CONTROL Psbo2
P< 1 0-8 9 False + at.05 level
2 COHORT
7 CAS E-CONTROL P <.01 3 False + at.05 level
~:SLZ OLSTS

Calculation of Annual Number of Lung Cancer Deaths
LUNG CANCER
FEMALES
MALES
Deaths N.S. 6,500 3,000
(19n $.0.) x .26 x .26
Attributable 1,690 780
to ETS
(never smoker)
Former Smokers 520 690
Total Attributable 2210 1470
to ETS
Total - 3,700 LCD's to non-smoker Attributable to ETS
BSLZ OLSTS

.Sofd/Q<e wu' Wi'llorimS' aNl Sd.ne"r', ~t'rK ftNAly s,"s
N
m
r-
~
~
Tebie IV. Relative Risks of Lung Cancer by Amount and Duration of Exposure :o
Spouse's Smoking
LO
Study No. ci8arettes/diy No. years of sm oking
Hireyama 0 ex 1-14 15- 19 20 + N ^.
~ 19841'" 1.0-1.4 1.4 1.6 1.9
,c Trichopoulos. 0 ex 1-20 21 ~ NA
19840" 1.0 1.9 1.9 2.5
Garfinkel. 0 < 1-19 20 20 4- NA
1981'3"
1.0 1.3
1.1
' Corna, 0 1-409" 41 +- Ak<Yr NA
I
t 19831'e1
1.0
1.5
3.1
Koo, 19840" 0 1-10 11-20 21 + 1-19 20-34 35 -
1.0 2.3 1.7 1.2 2.0 1.4 2.3
X Garfinkel, 0 1-10 11-19 20+0 Rllt - 2.9 for 20-29
1985~"' 1.0 1.2 1.1 2.1 yr, RRS fof > 29
yr vere lower
Wu, 1953M" NA 0 1-20 21 -
1.0 1.4 1.2
' "' =
--flala10ftr-. 0- 21-3, ::-:
-_
' 19 '0 2
_, . . . . . .
AbbI. 0 1-19 20-29 30 + 1-19 20-39 40 +
ac
19"s0
1.0
1.3
1.3 2.1 2
.1
1.3 0
1.3
Humble, 0 1-20 21 + 1 -26 27 + ~
19f1~"~ 1.0 2. 9 2.2 2 .2 2.7
~ Paskeses. 0 1-29pt& 30 + Pk/Yt' NA
-
1.0
1.0
3.2
Clo
190'1r"e NA « 20 20-29 30-39 40 + ~
, 1 .0 1.1 1.3 1.7
~- Ls, 190F'" 0 1-10 11-M 21 + NA
0 2
2 1
9 2
1
1. . .
.
A Ieory% 0 1-19 20+ NA
19iMAO
1Ali
3.1
~. GaO, 19p~"+ 0 1-0 10-1! 20 + 1-1' 20-3! 40 + ,~
, 1.0 1.4 2.0 2.8 1.3 2.2 3.3
P vwiw OOt a..w MR ro aPtort.
O" sot er.iMi9.
TR r"N~ Te STS
l1 S t'14o'cs
pRp6 (~ q Fs+1sP
< !O-g
-1-14 A Ll)
rRe.ra csTs
7 5 T44 Di,0s
~}'oB ~> ~ ffiLSe f- 1/'/0 E'4'ecT)
C .045
